Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4463071000168110 | methylprednisolone acetate 40 mg / 1 mL modified release injection, 1 x 1 mL vial (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4463081000168113 | methylprednisolone acetate 40 mg/mL modified release injection, 1 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| methylprednisolone acetate 40 mg/mL modified release injection, 1 mL vial | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| methylprednisolone acetate 40 mg/mL modified release injection, 1 mL vial | has MPUU | methylprednisolone acetate 40 mg/mL modified release injection, vial | true | Inferred relationship | Some | 1790567943 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Depo-Medrol 40 mg/mL modified release injection, 1 mL vial | Is a | True | methylprednisolone acetate 40 mg/mL modified release injection, 1 mL vial | Inferred relationship | Some | |
| Depo-Nisolone 40 mg/mL modified release injection, 1 mL vial | Is a | True | methylprednisolone acetate 40 mg/mL modified release injection, 1 mL vial | Inferred relationship | Some |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR